WACKER Launches Next-Gen Polysilicon Line in Germany 50 Percent Capacity Boost Targets Semiconductor Demand
On July 17, WACKER Chemie AG unveiled a new next-generation production line at its Burghausen site in Germany, dedicated to manufacturing ultra-high-purity polysilicon for the semiconductor sector. CEO Christian Hartel highlighted to over 100 guests that WACKER remains Europe’s only—and the world’s largest—supplier of semiconductor-grade polysilicon, underscoring its global technology leadership.
With this upgrade, WACKER increases its top-grade semiconductor polysilicon output by more than 50%, creating about 150 new jobs. The company aims to double its semiconductor customer sales by 2030 compared to 2024 through this major investment.
The expansion is part of the EU’s Important Projects of Common European Interest (IPCEI) in microelectronics and communication technologies. WACKER’s R&D innovations have secured up to €46 million in funding from the German Federal Ministry for Economic Affairs and Energy, the Bavarian Ministry for Economic Affairs, Regional Development and Energy, and the European Union.
You May Interested In
2026-07-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
WACKER Launches Next-Gen Polysilicon Line in Germany 50 Percent Capacity Boost Targets Semiconductor Demand
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
Torrent Pharma Targets First Wave Semaglutide Launch Revenue Up 11 Percent as Patent Ends
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
Jinggong Tech H1 Net Profit Soars 15 Percent Revenue Reaches 1.06 Billion Yuan Carbon Fiber Equipment Drives 59 Percent of Sales
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
Recommend Reading
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
India’s Tariff Cuts Could Lower Agrochemical Costs
-
Yangon Cuts Palm Oil Purchase Limit to 4.1kg per Order New Policy Effective August 4
-
Negative Factors Weighing Down, Hydrogen Peroxide Market Prices Decline Weakly in June
-
China's EVA Market Shows a Generally Weak and Consolidating Trend
-
Device Restart, Weak Consumption; PC Prices to Decline by Late June
-
What is Amylum Starch? (Old Terminology & Modern Equivalent)
-
Cost Decline, Weak Demand: October Phthalic Anhydride Prices Continue to Fall